Why the study?
Does serum troponin I measurement using an automated fluoroenzymometric assay improve diagnostic accuracy for acute myocardial infarction compared to traditional biochemical markers?
Does serum troponin I measurement using an automated fluoroenzymometric assay improve diagnostic accuracy for acute myocardial infarction compared to traditional biochemical markers?
Serum troponin I measured by fluoroenzymometric assay is a highly specific and sensitive marker for acute myocardial infarction, outperforming traditional markers in patients with skeletal muscle or renal disease.
No takes yet. Share an insight, caveat, or question.
Supports troponin I at 4 hours for AMI diagnosis; leaves open superiority over traditional markers in broader use.
Zaninotto et al. (1996) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: